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INTRODUCTION
Vertebral radiation therapy significantly increases the risk of post-treatment vertebral compression fracture (VCF) (1) (2) (3) (4) (5) . While bone is typically considered radiation-resistant, fractures frequently occur within the first year of SBRT (6) (7) (8) (9) (10) (11) . Radiation therapy is a risk factor for bone morbidity and fracture (12) (13) (14) (15) . Acute structural bone changes have been reported after pelvic (13) , lumbar spine (16, 17) and thoracic radiotherapy (6) , however, there is limited clinically relevant data on this topic.
Bone mineral density (BMD) and cortical thickness are two of the primary metrics used to quantitatively describe bone structural changes and predict for fracture risk (6, 18, 19) . The severity of radiation-induced structural changes appears to depend on both dose and age at time of exposure (17, 20, 21) . Wei et al. showed that doses as low as 5 Gy correlated with significant BMD loss (.20%) within just 4 months postirradiation, and this effect was persistent at 9-month follow-up (17) . While there is limited data from clinical studies on the acute changes in BMD after radiotherapy, there is a near-absence of literature describing the acute changes in cortical thickness after irradiation, which could predispose fracture (13) . This is due to limitations in conventional computed tomography (CT) resolution of follow-up scans. Both decreased cortical thickness and BMD may predispose those at highest risk of VCF towards progression and collapse with symptoms (22) . Early identification of those individuals at highest risk for radiation-induced bone changes could potentially allow for better selection of prophylactic interventions (15) . The effects of radiation are difficult to study using clinical data alone due to numerous confounding factors. These factors include chemotherapy (23) , steroids (24) , reduced mobility (25) and direct bony infiltration by tumor (26, 27) , which are all detrimental to bone health.
Non-human primates (NHPs) are a good model for studying bone-related changes that can be translated to expected responses in humans. NHPs exhibit both changes of normal aging and response to fractionated radiation that is well correlated with what has been shown in humans (28) (29) (30) (31) . In the current study, we assessed the subacute, longitudinal effects of radiation on vertebral structural properties (e.g., cortical thickness and BMD) in rhesus macaque NHPs when irradiated prior to or after skeletal maturity. Our goal was to determine if rapid deterioration of bone occurs in vertebrae of NHPs postirradiation, which could be assessed using our cortical thickness and dose mapping approach for measuring longitudinal architectural and density changes.
METHODS

Animals
Sixteen male rhesus monkeys (Macaca mulatta) received uniform total-chest irradiation using anterior-posterior parallel-opposed 6-MV X-ray beams. At time of exposure the ages of the NHPs ranged from 45-134 months old with a median of 57 months (young adults). Weights at time of exposure ranged from 4.4-11.25 kg. The animals were randomized into one of two treatment groups, which were administered either saline (n ¼ 7) or superoxide dismutase (SOD) mimetic ''Hexyl,'' a potential mitigator of radiation injury in lung (n ¼ 9, 0.125 mg/kg in a saline vehicle) (32) . Increased oxidative stress, with reduced cellular antioxidant defenses including SOD, is a putative mechanism for pathologic bone loss for many conditions, including estrogen deficiency at menopause (33, 34) . Thus, this treatment is a potential mitigator for any radiation-induced bone loss. Treatment was administered 24 h postirradiation and continued twice daily for the duration of the study. The original primary focus of the study was not bone outcomes, but rather pneumonitis and the extent and/or prevention of pulmonary toxicity.
Anesthesia Technique
Prior to radiation exposure each NHP was anesthetized with ketamine (5-15 mg/kg, intramuscular) and dexmedetomidine [0.0075-0.015 mg/kg, intramuscular (IM)] and then positioned supine with arms extended overhead. Atipamezole 0.0375-0.075 mg/kg IM was delivered for reversal of dexmedetomidine after irradiation.
Irradiation Technique
A clinical linear accelerator with 6 MV photons was used to deliver 10 Gy to the anterior-posterior midplane of the thorax of each animal, using a single 6-MV X-ray anterior (AP) field and a single 6-MV Xray posterior (PA) field in parallel-opposed, isocentric geometry. Open, rectangular oblong fields [X-Y field size dimensions of 13.0 cm (4.0 cm, 9.0 cm) 3 12.0 cm] were used without blocking of structures in the thorax with the field central axis placed at the xiphoid. Each field covered the superior aspect of the lungs and included the inferior lung to 4 cm below the xiphoid process. The lateral aspects of each lung and external skin surfaces were included within the radiation fields. The AP field included a 10 to 30-degree wedge (heel superior, angle determined from a CT scan of each animal) to compensate for the inferior-to-superior slope of the anterior chest wall, for improved dose homogeneity at midplane. Monitor units (dose delivery settings for the linear accelerator) were calculated assuming homogeneous tissue using measured animal AP diameters, grouping animals into three cohorts by their average AP dimensions.
Each anesthetized animal was placed in the irradiation position and imaged via electronic portal imaging [Elekta (Stockholm Sweden) iViewGTe amorphous silicon EPID on an Elekta Infinitye Linear Accelerator, 6-MV X rays] for the AP and then PA fields. The PA field was irradiated first, followed by the AP field (þ wedge) with a nominal dose rate of 6 Gy/min, 5 Gy per field, 10 Gy total to midplane. Each portal imaging procedure, an average of 2 image pairs per radiation field, delivered slightly less than 0.02 Gy, for a negligible additional dose to the midplane of 0.08 Gy (10.08 Gy total to midplane). A representative dose distribution is shown in Fig. 1 . All research was approved by the Wake Forest School of Medicine Institutional Animal Care and Use Committee (IACUC; WinstonSalem, NC).
Imaging and Vertebral Body Segmentation
Total-body CT scans were performed for all NHPs at 2 months prior to irradiation and then at 2, 4, 6 and 8 months postirradiation. Each CT scan was examined to identify bony pathologies, fractures and deformities. The thoracic and lumbar vertebrae were segmented from each CT scan using automated thresholding techniques and manual editing in Mimics software version 16.0 (Materialise, Leuven, Belgium). Intervertebral disks were excluded and only the bony anatomy was contoured. The vertebral bodies were isolated, and a 3-dimensional (3D) surface was constructed. The height and diameter of each vertebral body were obtained using measurement tools in Mimics. Each surface was registered to a canonical primate vertebral column using rigid and affine transforms in 3D Slicer software version 3.6 (https://www.slicer.org).
Cortical Thickness Analysis
Cortical thickness within each vertebra was measured using our cortical thickness radiation dose mapping approach (6, 13) . Cortical thickness was determined at 2,000 uniformly distributed vertices along the surface of each vertebral column using Stradwin software version FIG. 1. Two-plane dose distributions. Isodose curves in the coronal and sagittal planes for non-human primates (NHPs) receiving 10 Gy chest-only dose at the midplane. Note high isodoses, 50-105% within the irradiated volume and a gradient of low isodoses, 5 -0.5%, for the out-of-field volume inferior to the irradiated volume.
5.1 (Cambridge, England). Percentage change in cortical thickness at homologous vertices was calculated for all scans.
Trabecular Bone Mineral Density Analysis
Similarly, the mean CT density in Hounsfield units (HU) of homologous cylindrical trabecular bone volume in each vertebra was collected in Mimics from multiple slices in each vertebra roughly 2-4 mm apart, excluding end growth plates, and the average HU for each vertebra was obtained. All scans except six of the preirradiation (baseline) scans included a tissue density phantom consisting of materials of known tissue densities, used to convert HU into BMD. All scans were performed on the same CT machine and with the same tissue density phantom. For those six baseline scans that did not include the phantom during image acquisition, an average of the data from the scans that included the phantom was used to calculate BMD.
To assess density changes in out-of-field structures, the sacrum and pelvis were segmented using automated thresholding techniques and manual editing in Mimics. The average BMD of the pelvis was calculated at baseline and the 4-month time point and comparisons were made using paired t tests.
Pathologic Analysis of Bone Samples
Vertebral samples from the thoracic and lumbar spine were preserved in 10% neutral buffered formalin for 48 h prior to storage in 70% ethanol. In preparation for histology, vertebrae were decalcified with a 10% formic acid solution. Specimens were cut in sagittal cross section. Five micrometer representative sections of vertebral bone were cut with a microtome, placed on glass slides and stained with hematoxylin and eosin (H&E).
Statistical Analysis
Statistical analysis was performed using R version 3.2.4 software (R Foundation for Statistical Computing, Vienna, Austria). For NHPs that remained until study conclusion, BMD and cortical thickness were compared at all measured time points using repeated measures analysis of variance (ANOVA), with Bonferroni post hoc analyses performed for pairwise comparisons. For any NHP removed prior to the conclusion of the study before the 4-month time point, comparisons were made using paired t tests. Toxicity that resulted in removal from the study was compared using a Kaplan Meier analysis.
RESULTS
Eight NHPs were removed from the study between the 2-and 4-month time points due to pulmonary complications; NHPs younger than 50 months old at irradiation were more prone to a level of pulmonary toxicity that met criteria for a humane end point than those older than 50 months at irradiation (P ¼ 0.03), as shown in Fig. 2 . Pulmonary effects will be described in a future article.
A linear regression was performed to compare the BMD and cortical thickness in NHPs that received hexyl versus saline to determine any radioprotective effects on bone changes; hexyl treatment had no protective effect on the measured bone outcomes, as determined by comparing the linear regression slopes (Fig. 3) . Body weight increased from baseline during the follow-up period (Fig. 4) . The mean body weight prior to exposure was 6.9 kg and 7.12 kg at time of first follow-up. For those NHPs enrolled
FIG. 3.
No protective effect of hexyl on measured bone outcomes. Bone mineral density (panel A) and cortical thickness (panel B) were plotted using linear regression comparing animals that received hexyl vs. saline. Neither test was significant.
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throughout the study period, the mean body weight at time of last follow-up was 8.27 kg.
For NHPs that remained to the study conclusion, significant loss of cortical thickness in the in-field T9 occurred by 2 months postirradiation (P ¼ 0.0009), and this loss persisted to 8 months (Fig. 5B) . In contrast, no loss of cortical thickness was observed in vertebrae located out-offield, either L2 or L4. Reduced BMD in these animals was observed by 4 months postirradiation for T9 and by 6 months postirradiation for L2 and L4 (P , 0.01; Fig. 6 ). In those NHPs that were removed prior to study conclusion, both cortical thickness and BMD were lower in T9, L2 and L4 by 2 months postirradiation (P , 0.05; Figs. 5B and 6B). At an even more distant site, the whole pelvis, BMD was not different at the end point for those that were removed from the study prior to conclusion (2 months; P . 0.4) or in those that remained to study conclusion (8 months; P . 0.08). Histologically, the regions that exhibited the greatest degree of cortical thinning as determined from CT scans also exhibited increased cortical porosity (Fig. 7) .
DISCUSSION
As the use of high dose per fraction SBRT becomes more commonplace in modern practice, it is important to understand and quantify the effect of high-dose radiation on surrounding normal bone both inside and outside the treatment field. During thoracic and lumbar SBRT, bones are commonly exposed to relatively high doses of radiation (2, 6) . Standard fractionation regimens for lung tumors range from 10 to 18 Gy per fraction over a 3 to 5 fraction course (35) . In some situations, doses up to 34
Gy in a single fraction may be given to lung lesions (36) . This unavoidably exposes nearby healthy bone to high doses of radiation per fraction as well. There are currently limited data concerning the acute consequences of high dose per fraction irradiation to bone. A majority of the preclinical literature available has been focused on the late outcomes involving rodent or cell models with fractions of 2 Gy or less (12) (13) (14) (15) . The limited clinical studies on this topic have shown that thoracic SBRT is associated with changes in bone structural quality directly affecting bone strength. In their published work, Okoukoni et al. described significant cortical rib thinning in regions receiving 10 Gy after SBRT (6). Other published studies have shown an association between thoracic SBRT and a higher incidence of late rib fractures (approaching 40%) (7-9, 11, 37). Similarly, vertebral SBRT has been associated with increased progression of VCF (38) . Post-mortem analysis of vertebral bodies exposed to SBRT have demonstrated bone fracture, cortical thinning, necrosis and fibrosis (39) . Although the animals treated in the current study received radiation to their entire thoracic spine, extrapolation from these data could help shape our expectations of the types of bone changes we should anticipate after more localized treatments like SBRT. Such conformal therapies can expose one to several vertebral bodies to high doses of radiation per fraction on the order of those used here.
In this study, we observed rapid cortical thinning and trabecular bone loss after single-fraction 10 Gy whole-chest irradiation in a clinically applicable non-human primate (NHP) model. Postirradiation pulmonary toxicity was significantly correlated to the age at time of exposure, whereby younger NHPs were more sensitive to effects of radiation. Approximately 50% of the NHPs were removed due to complications suggestive of pneumonitis, with an average age of 51 months. The average age of those NHPs that lived to the study conclusion was 83 months. Interestingly, this coincides with the age of skeletal maturity (peak BMD) in male rhesus macaques, defined as 84 months by Cerroni et al. (40) .
Animals that died within 4 months postirradiation experienced rapid persistent bone loss by 2 months postirradiation throughout the vertebral spine at T9, L2 and L4 in both the trabecular and cortical compartments. Conversely, in those animals that survived to the end of the study, the cortical bone loss was confined to the radiation field only. In these older NHPs that were closer to skeletal maturity at the time of exposure, BMD change was noted by 4 months postirradiation in T9 and by 6 months in L2 and L4. Body weight increased as a function of time postirradiation (P ¼ 0.005; Fig. 4) . Therefore, the observed BMD changes were not related to reduced body weight (which is an accepted covariate for BMD) (41) .
The younger animals in this cohort may have experienced more significant growth and bone turnover than older animals, and their more rapidly growing cells may have been more sensitive to lower doses of radiation as well as more pronounced systemic inflammatory effects. For these animals the scatter and leakage dose in the lumbar spine, outside the defined radiation fields, was approximately 0.5-3% of the dose at the isocenter, which would correlate with doses of approximately 5-30 cGy (Fig. 1) . Doses on the order of 0.5-2 Gy have been shown in vivo and in vitro to stimulate an early increase in the number and function of osteoclasts (42) (43) (44) (45) . In clinical studies, doses as low as 5 Gy have been associated with rapid local bone loss (13) . This increased sensitivity of bone in the younger NHPs is also highlighted by the lack of changes in BMD at an even more distant site, the whole pelvis, which received no dose (Fig. 1) . Thus, the dose threshold for bone damage is unclear, but possibly very low. Given that these animals reached a humane end point due to pneumonitis-related toxicity, some of the bone changes observed may have also been related to decreased physical activity.
On histologic analysis trabeculae were qualitatively noted to be unusually thick and oddly shaped in multiple regions throughout the bone, with increased porosity throughout, but also with focal regions of pronounced cortical thickness. Additionally, there was ossification of cartilage above the growth plate and an apparent lack of bone turnover throughout the samples. Empty lacunae were not observed from the vertebrae. While hexyl was not observed to protect against bone loss, the actions of SOD in bone have been shown to have protective effects on bone osteoprogenitors and osteocytes (33, 34, 46) . These histologic findings correlated spatially with thinning identified from quantitative/3D models (Fig. 7) .
The radiation-induced structural bone changes are thought to be the result of multiple physiological processes affecting FIG. 5 . Median cortical thickness at the thoracic (T) and lumbar (L) vertebrae (whiskers 5-95%) as a function of time (months) after the baseline whole-body CT scan in NHPs removed prior to the study conclusion after the two-month follow-up (panel A) and in NHPs enrolled to the study conclusion (panel B). Chest-only irradiation occurred at two months after the baseline imaging was performed and this was set to time point t ¼ 0. Paired t test compared cortical thickness for NHPs that were removed prior to study conclusion, while repeated measures ANOVA with Bonferroni post hoc analyses were used for those NHPs that lived to the study conclusion. Bars and associated P values identify significant differences between individual groups; main ANOVA P value is presented above graph. The interassay coefficient of variation for each CT-based measure of cortical thickness for those that remained until study conclusion were 10.6-15.0% for T9, 11.1-12.9% for L2 and 9.2-12.4% for L4; and for those that were removed prior to the study conclusion were 10.6-15.2% for T9, 13.1-16.3% for L2 and 16.7-20.0% for L4.
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osteoblasts, osteoclasts and bone vascularity (15, 47) . Both in vitro and in vivo studies demonstrated that radiation directly damages osteoblasts and their precursors leading to impaired matrix production and lower BMD (14, 16, 48) . Early upregulation of osteoclast activity leading to rapid bone loss after irradiation has been reported in rodent models (15, 44, 49) . Radiation has been shown to cause an early and substantial increase the expression of proosteoclastogenic genes, including Rankl, Mcp1 and TNF- (44) . Young mice irradiated with an acute, high dose comparable to the chest dose in this study (7.25 and 8 .0 Gy) exhibited rapid loss of bone (50, 51) coincident with increased systemic biomarkers of TRAP5b (51), a circulating biomarker for osteoclast activity. Additionally, prophylactic use of osteoclast inhibitors have been shown to decrease acute radiation-induced bone loss in rodents (15) . Moreover, exposure of young mice to high-dose radiation (7.25 Gy) has been shown to reduce circulating biomarkers of bone formation and osteoblast activity, including sclerostin and procollagen type 1 amino-terminal propeptide (50) . Therefore, it is likely that the rapid bone loss seen here is facilitated by at least a contribution from both osteoclasts and osteoblasts, though rapid bone loss is likely a feature of elevated osteoclast activity.
This study presents several limitations. As noted, the primary study was intended to examine the protective effects of Hexyl on pulmonary toxicity. In this study, hexyl did not have a protective effect on bone morphology. The cohort of NHPs chosen were based on available samples at the initiation of the study, thus age and weight matching was not possible; however, this enabled us to detect that younger NHPs are more radiation-sensitive in terms of both bone loss and reaching end points associated with pneumonitis. Unfortunately, while the sample preparation for the histology permitted H&E staining, attempts at histochemical staining for osteoclast (TRAP) or osteoblast (ALP) number and activity failed. Thus, we are limited to presenting gross observational data.
FIG. 6.
Median bone mineral density at the thoracic (T) and lumbar (L) vertebrae (whiskers 5-95%) are presented as a function of time (months) after the baseline whole-body CT scan in NHPs removed prior to the study conclusion after the two-month follow-up (panel A) and in NHPs enrolled to the study conclusion (panel B). Chest-only irradiation occurred at two months after the baseline imaging was performed and this was set to time point t ¼ 0. Paired t test compared bone mineral density for NHPs that were removed prior to study conclusion, while repeated measures ANOVA with Bonferroni post hoc analyses were used for those NHPs that lived to the study conclusion. Bars and associated P values identify significant differences between individual groups; main ANOVA P value is presented above graph. The interassay coefficient of variation for each CTbased measure of bone mineral density for those that remained until study conclusion were 6.7-12.7% for T9, 11.3-16.7% for L2 and 14.6-17.7% for L4; and for those that were removed prior to the study conclusion were 13.3-18.1% for T9, 13.0-15.5% for L2 and 13.2-14.2% for L4.
CONCLUSION
Rapid and persistent cortical thinning and loss of BMD occurred after irradiation in these NHPs. Our data highlights the significance of early radiation-induced bone changes and their dependence on both dose and skeletal maturity. Additionally, younger age at exposure was associated with greater sensitivity to radiation. Future human trials are needed to confirm these findings. Nevertheless, the findings present interesting implications for clinical practice, illustrating the radiosensitivity of bone tissue. Patients with underlying diagnoses such as osteoporosis or pre-existing VCF may be at increased risk of progression or development of fractures. Considerations made to prevent exposure of normal bone during radiation treatment planning may decrease rates of later fractures. Importantly, the rapid rate of bone loss suggests an early increase in osteoclast activity, which is consistent with preclinical studies (15, 44) . If such radiation-induced changes are primarily due to an early upregulation of osteoclastic activity, then the use of osteoclast inhibitory therapies may provide some degree of bone radioprotection; and the osteoclast can be identified as a prime target for therapeutics to prevent the debilitating radiation therapy-induced fractures in cancer patients. Additionally, the cortical thickness dose-mapping approach for measuring subacute bone loss across time as applied in this NHP model can be translated to clinically identify those patients at highest risk for skeletal complications after SBRT.
